May 8, 2014 | ICON today completed the acquisition of Aptiv Solutions. Aptiv Solutions is focused on design and execution of adaptive clinical trials (see, Taking on an Adaptive Dose Response Model), and also has a Japanese CRO subsidiary. The acquisition took place for cash consideration of $143.5 million. Press release.